Medpace Holdings Total Current Assets 2014-2024 | MEDP
Medpace Holdings total current assets from 2014 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
- Medpace Holdings total current assets for the quarter ending June 30, 2024 were $0.873B, a 130.26% increase year-over-year.
- Medpace Holdings total current assets for 2023 were $0.594B, a 77.81% increase from 2022.
- Medpace Holdings total current assets for 2022 were $0.334B, a 51.66% decline from 2021.
- Medpace Holdings total current assets for 2021 were $0.691B, a 45.87% increase from 2020.
| Medpace Holdings Annual Total Current Assets (Millions of US $) |
|
|---|---|
| 2023 | $594 |
| 2022 | $334 |
| 2021 | $691 |
| 2020 | $474 |
| 2019 | $317 |
| 2018 | $178 |
| 2017 | $130 |
| 2016 | $133 |
| 2015 | $95 |
| 2014 | $133 |
| 2013 | $ |
| Medpace Holdings Quarterly Total Current Assets (Millions of US $) |
|
|---|---|
| 2024-06-30 | $873 |
| 2024-03-31 | $745 |
| 2023-12-31 | $594 |
| 2023-09-30 | $449 |
| 2023-06-30 | $379 |
| 2023-03-31 | $368 |
| 2022-12-31 | $334 |
| 2022-09-30 | $338 |
| 2022-06-30 | $329 |
| 2022-03-31 | $356 |
| 2021-12-31 | $691 |
| 2021-09-30 | $641 |
| 2021-06-30 | $550 |
| 2021-03-31 | $533 |
| 2020-12-31 | $474 |
| 2020-09-30 | $395 |
| 2020-06-30 | $319 |
| 2020-03-31 | $303 |
| 2019-12-31 | $317 |
| 2019-09-30 | $250 |
| 2019-06-30 | $194 |
| 2019-03-31 | $182 |
| 2018-12-31 | $178 |
| 2018-09-30 | $153 |
| 2018-06-30 | $158 |
| 2018-03-31 | $154 |
| 2017-12-31 | $130 |
| 2017-09-30 | $117 |
| 2017-06-30 | $123 |
| 2017-03-31 | $128 |
| 2016-12-31 | $133 |
| 2016-09-30 | $121 |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | |
| 2014-12-31 | $133 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.201B | $1.886B |
| Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $125.093B | 15.25 |
| Cencora (COR) | United States | $45.021B | 17.20 |
| ICON (ICLR) | Ireland | $24.951B | 22.42 |
| DiDi Global (DIDIY) | China | $18.956B | 0.00 |
| Avantor (AVTR) | United States | $18.396B | 27.90 |
| Natera (NTRA) | United States | $15.720B | 0.00 |
| Revvity (RVTY) | United States | $15.367B | 26.91 |
| Viatris (VTRS) | United States | $14.203B | 4.33 |
| CochLear (CHEOY) | Australia | $12.751B | 0.00 |
| Solventum (SOLV) | United States | $12.458B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.641B | 20.11 |
| Sonic Healthcare (SKHHY) | Australia | $8.811B | 0.00 |
| Doximity (DOCS) | United States | $7.438B | 47.13 |
| Bausch + Lomb (BLCO) | Canada | $7.041B | 30.30 |
| HealthEquity (HQY) | United States | $6.771B | 36.75 |
| PACS (PACS) | United States | $6.218B | 0.00 |
| Organon (OGN) | United States | $5.142B | 5.23 |
| Life Times (LTH) | United States | $4.879B | 40.78 |
| Sotera Health (SHC) | United States | $4.741B | 23.91 |
| Surgery Partners (SGRY) | United States | $4.088B | 45.30 |
| Concentras Parent (CON) | United States | $2.955B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $2.789B | 105.00 |
| BrightSpring Health Services (BTSG) | United States | $2.550B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.438B | 0.00 |
| Progyny (PGNY) | United States | $2.206B | 38.79 |
| Alignment Healthcare (ALHC) | United States | $2.177B | 0.00 |
| Premier (PINC) | United States | $2.052B | 9.23 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.921B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.778B | 8.93 |
| Agilon Health (AGL) | United States | $1.642B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.556B | 0.00 |
| CareDx (CDNA) | United States | $1.543B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.183B | 0.00 | |
| GeneDx Holdings (WGS) | United States | $1.044B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.933B | 24.43 |
| Pediatrix Medical (MD) | United States | $0.933B | 10.15 |
| Embecta (EMBC) | United States | $0.895B | 5.97 |
| InnovAge Holding (INNV) | United States | $0.812B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.551B | 0.00 |
| Sharecare (SHCR) | United States | $0.527B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.499B | 0.00 |
| Enhabit (EHAB) | United States | $0.410B | 35.48 |
| Sonida Senior Living (SNDA) | United States | $0.370B | 0.00 |
| DocGo (DCGO) | United States | $0.361B | 13.58 |
| Sera Prognostics (SERA) | United States | $0.261B | 0.00 |
| Biodesix (BDSX) | United States | $0.253B | 0.00 |
| LifeMD (LFMD) | United States | $0.226B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.194B | 0.00 |
| ModivCare (MODV) | United States | $0.192B | 6.11 |
| Beauty Health (SKIN) | United States | $0.187B | 0.00 |
| MultiPlan (MPLN) | United States | $0.152B | 0.00 |
| Nutex Health (NUTX) | United States | $0.126B | 0.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.083B | 0.00 |
| So-Young (SY) | China | $0.081B | 19.72 |
| Singular Genomics Systems (OMIC) | United States | $0.042B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.66 |
| Co-Diagnostics (CODX) | United States | $0.041B | 0.00 |
| OncoCyte (OCX) | United States | $0.039B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.030B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.028B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.026B | 0.00 |
| Oncology Institute (TOI) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.021B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.010B | 0.00 |
| KindlyMD (KDLY) | $0.008B | 0.00 | |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |